DUCHENE TODD M 4

What Happened Todd M. Duchene, Core Scientific’s Chief Legal and Administrative Officer, sold a total of 10,000 shares in open-market transactions on June 22, 2026 for aggregate proceeds of about $292,939. The sales broke down as 7,600 shares at a weighted average price of $29.11 (≈ $221,238) and 2,400 shares at a weighted average price of $29.88 (≈ $71,701). These were sales (not purchases), commonly a routine liquidity event rather than a direct bullish signal.

Key Details

• Transaction date: June 22, 2026; Form filed June 24, 2026 (appears timely).
• Sales: 7,600 shares @ weighted avg $29.11 (≈ $221,238); 2,400 shares @ weighted avg $29.88 (≈ $71,701); total 10,000 shares for ≈ $292,939.
• Footnotes: Transactions were executed under a Rule 10b5-1 trading plan adopted Dec 5, 2025 (pre‑scheduled trading). Reported prices are weighted averages; the 7,600-share trades occurred across prices from $28.61 to $29.58, and the 2,400-share trades ranged $29.64 to $30.32. The filer will provide per-price breakdowns on request.
• Shares owned after the transaction: not specified in the excerpted data provided.
• Filing timeliness: filed two days after the trade date, consistent with Form 4 timing requirements.

Context Because these sales were made under a pre-established 10b5-1 plan, they were likely scheduled in advance; such plans are commonly used to avoid questions about trading on inside information. For retail investors, scheduled insider sales are informational but do not necessarily reflect changed views on the company’s prospects.